Neoadjuvant chemotherapy after liver transplantation for hepatocellular carcinoma.
Rizzi
P M
PM
Institute of Liver Studies, King's College Hospital, London, United Kingdom.
Ryder
S D
SD
Ramage
J K
JK
Gane
E
E
Karani
J
J
Heaton
N
N
Portmann
B
B
Tan
K C
KC
Williams
R
R
D006528:Carcinoma, Hepatocellular / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology / Q000601:surgery; D017024:Chemotherapy, Adjuvant; D004317:Doxorubicin / Q000627:therapeutic use*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007165:Immunosuppression Therapy; D008113:Liver Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology / Q000601:surgery; D016031:Liver Transplantation / Q000401:mortality; D008297:Male; D008875:Middle Aged; D012008:Recurrence; D012189:Retrospective Studies; D015996:Survival Rate; D013997:Time Factors; D000509:alpha-Fetoproteins / Q000032:analysis
D000509:alpha-Fetoproteins; D004317:Doxorubicin